Chemical name: 2,2′-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile)
Formula: C17H19N5
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid

ARIMIDEX 1mg – DRAGON PHARMA

Description: ARIMIDEX 1mg, manufactured by Dragon Pharma, is an oral medication containing the active ingredient Anastrozole. Each tablet typically contains 1 milligram of Anastrozole.

Indications: ARIMIDEX 1mg is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is commonly prescribed as adjuvant therapy following surgery or radiation therapy to reduce the risk of cancer recurrence. Additionally, ARIMIDEX 1mg may be used as first-line or second-line therapy in advanced or metastatic breast cancer.

Mechanism of Action: Anastrozole is a non-steroidal aromatase inhibitor that works by inhibiting the enzyme aromatase, which is responsible for the conversion of androgens into estrogens. By reducing estrogen levels in the body, Anastrozole helps slow down or inhibit the growth of estrogen-sensitive breast cancer cells.

Administration: ARIMIDEX 1mg is administered orally in the form of tablets. The dosage and duration of treatment may vary depending on individual patient factors, disease stage, and response to therapy. It is essential to follow the prescribed dosage and administration schedule as directed by a healthcare provider.

Dosage and Treatment Plan: The typical dosage of ARIMIDEX 1mg for breast cancer is one tablet (1 mg) taken once daily. Treatment may be continued for several years, depending on the individual patient’s response and tolerance to the medication.

Side Effects: Common side effects associated with ARIMIDEX 1mg may include hot flashes, joint pain, fatigue, headache, nausea, and bone thinning (osteoporosis). Rare but serious side effects may include allergic reactions, liver dysfunction, and an increased risk of cardiovascular events.

Precautions:

• ARIMIDEX 1mg should be used with caution in individuals with pre-existing medical conditions such as liver disease, cardiovascular disease, or osteoporosis.
• It is not recommended for use in premenopausal women or individuals with hypersensitivity to Anastrozole or any component of the formulation.

Consultation with a Healthcare Provider: Before starting treatment with ARIMIDEX 1mg, individuals should consult with a healthcare provider or qualified medical professional. They can provide guidance on proper usage, dosage, and potential risks associated with the medication. It is essential to undergo regular monitoring and evaluation to ensure safety and efficacy during treatment.